Zhitong Finance App News, Innox (688710.SH) issued an announcement. The company has undergone a comprehensive on-site inspection of Good Laboratory Practice (GLP) from the US Food and Drug Administration (“FDA”) within 2026. Recently, the company received an on-site inspection report (EIR) issued by the FDA. The report indicates that based on the requirements of the US 21 CFR regulation (Chapter 21 of the US Federal Regulations), the FDA has confirmed that this inspection has been completed. The letter indicates that the company complies with the FDA's Good Laboratory Practice (GLP) regulations, that the information submitted to the FDA is scientific and reliable, and successfully passed this FDA knock-on supervision inspection. The results of the inspection were voluntary action (VAI).

Zhitongcaijing · 2d ago
Zhitong Finance App News, Innox (688710.SH) issued an announcement. The company has undergone a comprehensive on-site inspection of Good Laboratory Practice (GLP) from the US Food and Drug Administration (“FDA”) within 2026. Recently, the company received an on-site inspection report (EIR) issued by the FDA. The report indicates that based on the requirements of the US 21 CFR regulation (Chapter 21 of the US Federal Regulations), the FDA has confirmed that this inspection has been completed. The letter indicates that the company complies with the FDA's Good Laboratory Practice (GLP) regulations, that the information submitted to the FDA is scientific and reliable, and successfully passed this FDA knock-on supervision inspection. The results of the inspection were voluntary action (VAI).